Sort
65,743 grants matching “single cell sequencing”
T cell-targeted lentiviral vectors with Cas9/RNP for the in vivo gene therapy of HIV-AIDS
$683,236Priti Kumar · Yale University · R01 · FY2019 · AI
Proteolysis in the Pathogenesis of ARDS
$683,217Gregory Paul Downey · National Jewish Health · R01 · FY2025 · HL
Smooth muscle cell-derived cell fates and cellular interactions in atherosclerotic plaque stability in disease progression and regression.
$683,214Muredach P Reilly · Columbia University Health Sciences · R01 · FY2024 · HL
Oxidative DNA Damage Repair in Premature Aging and Neurodegeneration
$683,210David Wilson · National Institute On Aging · ZIA · FY2017 · AG
Rheumatoid Arthritis and the Risk of Cardiovascular Disease: Biomarkers Risk Prediction and Underlying Mechanisms
$683,150Daniel Hal Solomon · Brigham And Women'S Hospital · R01 · FY2022 · HL
Molecular analysis of the mucosal SIVsmm transmission bottleneck
$683,133George M Shaw · University Of Pennsylvania · P01 · FY2012 · AI
Discovery and manipulation of transcription factors to restore long term stem cell repopulation in aged bone-marrow
$683,120Omar O Abudayyeh · Brigham And Women'S Hospital · R01 · FY2025 · AG
Development of Recombinant Toxins to Treat Hematologic Malignancies
$683,093Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
B and Tfh cell dynamics underlying durable antibody responses to flu vaccine in children
$683,050Harinder Singh · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · AI
Novel pathogenesis of LVNC
$683,048Deqiang Li · Research Inst Nationwide Children'S Hosp · R01 · FY2025 · HL
OMICs to define impact of cocaine on immunity and HIV persistence in treated HIV infection
$683,045Rafick-Pierre Sekaly · Case Western Reserve University · R01 · FY2017 · DA
Comparative Genomics of Precursor Diversity and Function
$683,039Tarik F Haydar · Children'S Research Institute · R01 · FY2021 · NS
ATOL: Collaborative Research: Deep Green Plant Phylogenetics: Novel Analytical Methods for Scaling Data from Genomics to Morphology
$683,000Brent Mishler · University Of California-Berkeley · · FY2002 · BIO
Elucidating the Role of Regulatory T cells in Establishing and Maintaining a Th2 Niche in Skin
$682,917Michael David Rosenblum · University Of California, San Francisco · R01 · FY2024 · AR
Unraveling the molecular pathology of retinal degeneration through single cell genomics
$682,915Radha Ayyagari · University Of California, San Diego · R01 · FY2024 · EY
Genomic and environmental drivers of HCC in Non-Hispanic Blacks: Nature and nurture
$682,915Andrea D. Branch · Icahn School Of Medicine At Mount Sinai · U01 · FY2025 · CA
Targeting Mineralocorticoid Receptor Condensates to Optimize Donor Heart Preservation
$682,912Paul Tang · University Of Michigan At Ann Arbor · R01 · FY2023 · HL
Cytomegalovirus manipulation of functional cortical tissue development
$682,879Allison D Ebert · Medical College Of Wisconsin · R01 · FY2025 · AI
Characterizing proviral populations in brain tissues
$682,808David Mitchell Smith · University Of California, San Diego · R33 · FY2018 · DA
Age, Gene/Environment Susceptibility Study
$682,780Tamara Harris · National Institute On Aging · Z01 · FY2008 · AG
Immunogenetic determinants of cancer risk
$682,727Robert M Samstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Integrated Molecular and Cellular Drivers of Alveologenesis
$682,722Jennifer Malcolmsrygley Sucre · Vanderbilt University Medical Center · R01 · FY2025 · HL
Improving Outcome in Patients with Advanced Intrahepatic Cholangiocarcinoma: A Randomized Phase II Study of Gemcitabine and Oxaliplatin With or Without Regional Floxuridine (FUDR)
$682,721William Robert Jarnagin · Sloan-Kettering Inst Can Research · U01 · FY2020 · CA
Targeting T cell dysfunction in glioblastoma: A proof-of-concept Phase 0/I trial of anti-TIGIT antibody AB154 in combination with anti-PD1 antibody AB122
$682,689David A. Hafler · Yale University · R01 · FY2025 · CA
CD38 modulation of NAD metabolism driving scleroderma pathogenesis
$682,658John Varga · University Of Michigan At Ann Arbor · R01 · FY2023 · AR